Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

NCT03109886 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Milciclib maleate

Sponsor

Tiziana Life Sciences LTD